- Home
- BHE vs SPRY Comparison
BHE vs SPRY Comparison
Compare BHE & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHE
- SPRY
- Stock Information
- Founded
- BHE 1979
- SPRY 2015
- Country
- BHE United States
- SPRY United States
- Employees
- BHE N/A
- SPRY N/A
- Industry
- BHE Electrical Products
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- BHE Technology
- SPRY Health Care
- Exchange
- BHE Nasdaq
- SPRY Nasdaq
- Market Cap
- BHE 1.3B
- SPRY 1.8B
- IPO Year
- BHE 1990
- SPRY N/A
- Fundamental
- Price
- BHE $39.26
- SPRY $17.88
- Analyst Decision
- BHE Strong Buy
- SPRY Strong Buy
- Analyst Count
- BHE 2
- SPRY 4
- Target Price
- BHE $47.00
- SPRY $28.75
- AVG Volume (30 Days)
- BHE 186.2K
- SPRY 1.3M
- Earning Date
- BHE 07-30-2025
- SPRY 08-05-2025
- Dividend Yield
- BHE 1.75%
- SPRY N/A
- EPS Growth
- BHE N/A
- SPRY N/A
- EPS
- BHE 1.44
- SPRY N/A
- Revenue
- BHE $2,612,294,000.00
- SPRY $97,122,000.00
- Revenue This Year
- BHE $0.52
- SPRY N/A
- Revenue Next Year
- BHE $8.50
- SPRY $170.64
- P/E Ratio
- BHE $27.01
- SPRY N/A
- Revenue Growth
- BHE N/A
- SPRY 971120.00
- 52 Week Low
- BHE $30.73
- SPRY $8.91
- 52 Week High
- BHE $52.57
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- BHE 50.47
- SPRY 56.00
- Support Level
- BHE $38.47
- SPRY $17.70
- Resistance Level
- BHE $40.51
- SPRY $18.63
- Average True Range (ATR)
- BHE 0.96
- SPRY 0.65
- MACD
- BHE -0.11
- SPRY -0.10
- Stochastic Oscillator
- BHE 37.11
- SPRY 47.92
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.